N*1*-(6-Morpholin-4-yl-3-nitro-4-trifluoromethyl-pyridin-2-yl)-propane-1,3-diamine CAS 1089330-47-1
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 1089330-47-1 |
| Molecular Formula | C13H18F3N5O3 |
| Molecular Weight | 349.31 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
N*1*-(6-Morpholin-4-yl-3-nitro-4-trifluoromethyl-pyridin-2-yl)-propane-1,3-diamine (CAS 1089330-47-1) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C13H18F3N5O3. Molecular weight: 349.31 g/mol. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.
Physical & Chemical Properties
| Molecular Formula | C13H18F3N5O3 |
| Molecular Weight | 349.31 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1989 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 5 |
Related N Standards
- 4-Methyl-11-(morpholin-4-yl)-8-thia-12-azatetracyclo[8.8.0.0^{2,7}.0^{13,18}]octadeca-1(18),2,4,6,10,12,14,16-octaene (CAS 866136-65-4)
- 7-(Morpholin-4-yl)-2,4-bis(trifluoromethyl)-1,8-naphthyridine (CAS 241488-26-6)
- N-[3-(Morpholin-4-yl)propyl]-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine (CAS 2490666-11-8)
- 4-Methyl-5-(2-{[2-(morpholin-4-yl)ethyl]amino}acetyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one (CAS 866156-79-8)
- (3-Morpholin-4-yl-5-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester (CAS 641571-04-2)
- 3-(2-Morpholin-4-yl-5-trifluoromethyl-pyridin-3-yl)-benzoic acid (CAS 1311280-20-2)
- 4-(2-Morpholin-4-yl-5-trifluoromethyl-pyridin-3-yl)-benzoic acid (CAS 1311280-21-3)
- 4-[4-(Morpholin-4-yl)-3-nitrophenyl]-1,2-dihydrophthalazin-1-one (CAS 488137-27-5)
Recommended Standards
- Clomipramine EP Impurity D (CAS 3589-22-8)
- (3R,4R,5S,6S)-3-acetamido-6-(fluoromethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate (CAS 1094213-88-3)
- Ethyl 5-hydroxy-3-(4-methoxyphenyl)-2-methyl-5-(trifluoromethyl)-1,2-oxazolidine-4-carboxylate (CAS 321391-89-3)
- LBP-1 (CAS 1050478-18-6)
- 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde (CAS 728864-61-7)
- 1346604-31-6 2,2'-(4-Bromo-1-butenylidene)bis-3-methyl-d6-thiophene (CAS 1346604-31-6)
- 2-((Dimethylamino)methyl)-3,4-dihydronaphthalen-1(2H)-one (CAS 7353-59-5)
- 4-Cyclopropoxy-N2,N2-dimethylpyridine-2,3-diamine (CAS 1243281-83-5)
- Ethyl 4,6-dimethoxy-3-methyl-1H-indole-2-carboxylate (CAS 1134334-78-3)
- Fas C- Terminal Tripeptide (CAS 189109-90-8)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com